Cargando…
Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease?
Autores principales: | Marongiu, Francesco, Barcellona, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567638/ https://www.ncbi.nlm.nih.gov/pubmed/33083688 http://dx.doi.org/10.1055/s-0040-1719232 |
Ejemplares similares
-
Thrombosis centres and AVKs monitoring in COVID-19 pandemic
por: Barcellona, Doris, et al.
Publicado: (2020) -
Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
por: Barcellona, Doris, et al.
Publicado: (2018) -
The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018) -
Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021) -
Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)